Electromed (NYSE:ELMD) Announces Quarterly Earnings Results

Electromed (NYSE:ELMD) announced its quarterly earnings results on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.13, Zacks reports. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The business had revenue of $14.67 million during the quarter.

Electromed Stock Performance

Shares of ELMD traded down $0.01 during trading hours on Friday, reaching $28.88. The stock had a trading volume of 36,060 shares, compared to its average volume of 41,466. The company’s 50-day moving average is $21.67 and its two-hundred day moving average is $17.65. The stock has a market capitalization of $244.32 million, a PE ratio of 40.11 and a beta of 0.27. Electromed has a 12 month low of $9.81 and a 12 month high of $30.00.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.